SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences (WVE) is trending due to promising interim Phase 1 data for its obesity drug candidate, WVE-007, which demonstrated significant fat loss with muscle preservation and the potential for convenient once or twice-yearly dosing, distinguishing it from existing GLP-1 treatments. This differentiated profile is generating considerable buzz and analyst upgrades, positioning WVE as a key player in the rapidly expanding and competitive obesity market where major pharmaceutical companies are actively seeking next-generation therapies.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending due to multiple acquisition offers from major players like Hapag-Lloyd and MSC, with its board rejecting a lower CEO bid and the community anticipating a potential short squeeze and significantly higher payouts, despite ongoing complexities related to Israeli government and union approvals.

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Ventyx Biosciences is actively discussed following Eli Lilly's $1.2 billion acquisition offer, as the community anticipates a bidding war for its advanced NLRP3 inhibitor pipeline, which boasts compelling cardiovascular and neuro-inflammatory data and significant synergistic potential with GLP-1 agonists.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is surging in conversation driven by its fiercely dedicated "Rage Bros" community, which exhibits "delusional & retarded" conviction and relentless "bagworking" to position this OG meme coin on Solana for a future "51B" valuation. This active community believes it's building a foundational project that will lead the next meme bull run.

Sysco Corp. engages in the selling, marketing, and distribution of food products to restaurants, healthcare and educational facilities, and lodging establishments. It operates through the following segments: U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other. The U.S. Foodservice Operations segment consists of U.S. Broadline operations, custom-cut meat and seafood companies, FreshPoint, and European Imports. The International Foodservice Operations segment includes operations outside of the United States which distribute a full line of food products and a wide variety of non-food products. The SYGMA segment represents U.S. customized distribution operations serving quick-service chain restaurant customer locations. The Other segment covers hotel supply operations. The company was founded by John F. Baugh in 1969 and is headquartered in Houston, TX.

Sysco Corp.

Sysco is seeing increased activity following its recent Investor Day, where management presented optimistic growth strategies and long-term targets, coupled with several positive earnings reports and widespread analyst upgrades that are fueling community discussion about the company's defensive strength in the foodservice sector.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is seeing significant discussion driven by persistent rumors of a "COEP merger" with a major mining entity and speculation around X platform's potential crypto integration. This has sharply divided the community, with many anticipating a substantial rally and short squeeze, while others strongly warn of an imminent pump and dump.

Ethereum Classic

Ethereum Classic is trending with highly polarized community sentiment, as many are frustrated by its prolonged decline while others actively accumulate, expecting a significant rebound during an anticipated "altcoin season" fueled by broader crypto market liquidity and regulatory developments.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF ($SMH) is experiencing significant discussion as positive analyst commentary and strong earnings from its core holdings propel the sector to new highs, fueling a community debate between sustained AI-driven growth and concerns over its "parabolic" valuation. Bullish options plays indicate some anticipate continued upside, contrasting with calls for an imminent pullback and sector rotation.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending due to upcoming Supreme Court and antitrust rulings, coupled with positive preliminary Q4 financials and strategic positioning after its exclusion from China's drug list. The community is actively discussing a potential acquisition, notably by Novartis, as the company's financial health improves and its advanced patent portfolio gains clarity.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is trending amidst active community debate over potential credit card interest rate caps, with many seeing it as political noise that could indirectly affect transaction volumes. Simultaneously, optimism is fueled by its strategic moves into stablecoin settlements and AI-driven commerce, reinforcing its position in the evolving digital payments landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shell Asset Management Co. Sells 4,478 Shares of Alnylam Pharmaceuticals, Inc. $ALNY

Shell Asset Management Co. cut its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 61.7% during the third quarter, according to the company in its most recent Form 13F filing...

Aberdeen Group plc Sells 61,228 Shares of Alnylam Pharmaceuticals, Inc. $ALNY

Aberdeen Group plc lessened its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 28.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange...

12,116 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Purchased by Cibc World Market Inc.

Cibc World Market Inc. purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the...

Alnylam Pharmaceuticals (NASDAQ:ALNY) Lowered to "Buy" Rating by Wall Street Zen

Wall Street Zen cut shares of Alnylam Pharmaceuticals from a "strong-buy" rating to a "buy" rating in a research report on Saturday...

ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down

Alnylam tops Q4 earnings estimates but misses on sales despite 85% revenue growth, as booming Amvuttra demand fails to lift shares.

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Lowered to $425.00 at Chardan Capital

Chardan Capital lowered their target price on shares of Alnylam Pharmaceuticals from $475.00 to $425.00 and set a "buy" rating on the stock in a research note on Friday...

Rhumbline Advisers Sells 3,988 Shares of Alnylam Pharmaceuticals, Inc. $ALNY

Rhumbline Advisers decreased its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 2.0% in the third quarter, according to its most recent disclosure with the Securities...

Why Alnylam Pharmaceuticals Stock Slipped Today

Key PointsThe biotech released its final set of figures for 2025...

Needham & Company LLC Has Lowered Expectations for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price

Needham & Company LLC decreased their price objective on Alnylam Pharmaceuticals from $529.00 to $510.00 and set a "buy" rating for the company in a research report on Thursday...

Alnylam Pharmaceuticals (NASDAQ:ALNY) Issues Quarterly Earnings Results

Alnylam Pharmaceuticals (NASDAQ:ALNY - Get Free Report) posted its earnings results on Thursday. The biopharmaceutical company reported $0.82 EPS for the quarter, missing the consensus estimate of...

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

ALNY
Alnylam Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALNY News

ALNYAlnylam Pharmaceuticals Inc